Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 600-735-2 | CAS number: 106276-79-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
There are no studies available in which the toxicokinetic properties of the test substance were investigated. Based on the large molecular size, the absence of adverse findings in toxicity studies, and the presence of functional groups for metabolism, a potential for bioaccumulation is unlikely. Further details for this assessments are given below.
Chemistry
The test substance (molecular weight of 656 Da) is a yellow powder those water solubility (deionised water) is < 32 µg/l. The solubility in different organic solvents is low to very low (< 10 mg/100ml), the logPow is calculated to be 0.5. The melting point is above 400°C which excludes vaporisation of the test material. Examination of the particle size distribution revealed a MMD of 2.5 µm (D10 1.27 µm, D90 26.95 µm). With regard to the molecular structure of the substance and the poor solubility in water, hydrolysis is not likely.
Absorption
In an acute oral and inhalation toxicity study (analogue substance), rats were administered to the test substance. No mortalities or clinical signs of toxicity were observed at doses of 5000 mg/kg bw and 1.04 mg/l air, respectively, indicating primarily a very low level of oral and inhalation toxicity. The NOAEL in male and female rats in a subacute oral repeated dose study on a structural analogue is 1000 mg/kg bw/day. With regard to the poor water solubility and the absence of hydrolysable groups, the test substance cannot undergo pH-dependent hydrolysis in the stomach. Due to the high molecular weight (> 500 g/mol) gastrointestinal absorption is very limited. As it does not bear resemblance to fatty acids, uptake via micelles with bile acids is unlikely.
Skin penetration can be excluded based on model calculation (Fitzpatrick, et al., 2004).
The test substance has a comparably very low vapour pressure. This indicates that absorption of the substance via vapour inhalation is not relevant.
Metabolism
Single oral application of the test item to male and female rats did not provoke any effect than yellow stained feces. Oral administration of an analogue substance to Wistar rats at doses of 100, 300 and 1000 mg/kg bw/day, for 28 days resulted in no test item-related effects and no differences in food consumption or body weight development. The hematology, clinical biochemistry and urinalysis parameters did not show test item-related differences when compared with those of the controls. Organ weights of test item-treated animals were unaffected, and macroscopical/microscopical findings were of no toxicological relevance.
Based on the results of this study, 1000 mg/kg bw/day was considered to be the no observed- adverse-effect-level (NOAEL).
No indication of uptake or chemical reactivity was observed in any study, including acute studies, irritation, sensitization and genotoxicity in vitro as well as the above described subacute study.
In case the substance is absorbed via the gastrointestinal system, the material will be transported to the liver. Possible degradation by metabolising enzymes may cause formation of benzenendiamine. Benzenediamine is highly toxic, irritating and a strong sensitizer. Single or double oral application of the test item at high concentrations (acute oral toxicity testing, micronucleus assay) did not reveal mortality or signs of toxicity. Instead, excretion of yellow or orange stained feces was observed indicating a lack of enzymatic or bacterial degradation. Rather than formation of benzenediamine, substitution of chlorine by glutathion and subsequent excretion of the conjugated metabolite via urine is possible.
Excretion
As mentioned above, the substance is expected to be excreted unchanged via the feces. In case of gastrointestinal uptake and metabolism through hydroxylation and phase-II substitution of chlorine it is expected that the test substance might be excreted predominantly via the urine. Overall, the test substance is not expected to accumulate in the body.
Used references:
Fitzpatrick, D., et al. (2004). "Modelling skin permeability in risk assessment-the future." Chemosphere 55 (10): 1309-14.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.